Compounders Research Compare

Aprea Therapeutics, Inc.(APRE)

Biotechnology · Boston, PA

$0.64-0.04 (-5.94%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways. The company's primary drug candidate, ATRN-119, is an oral ATR inhibitor currently undergoing Phase 1/2a clinical trials for patients with advanced solid tumors. Beyond this lead compound, Aprea's developmental pipeline includes ATRN-Backup, which is also an ATR inhibitor; ATRN-W1051, being explored for its anti-tumor effects; and ATRN-DDRi. Aprea Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Boston, PA

8 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Oren Gilad

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T21:40:44.758Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:40:44.758Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.08
Quote price: 0.6355

FMP input reference: d88ebff11657cb0645ea93f74423bc241bf41286751ec96f31399ab1bd3406dc

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

APRE Earnings Yield Metrics

EARNINGS YIELD

N/A

APRE Competitors' Earnings Yield

Aprea Therapeutics, Inc.

Current

Market Cap

$7.87M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Traws Pharma, Inc.

Market Cap

$7.92M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNS Pharmaceuticals, Inc.

Market Cap

$7.75M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GT Biopharma, Inc.

Market Cap

$8.04M

Earnings Yield

N/A

TTM Avg

1206.46%

3Y Avg

1192.40%

5Y Avg

1192.40%

DataMEDS AI, Inc.

Market Cap

$8.05M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENDRA Life Sciences Inc.

Market Cap

$7.67M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Mangoceuticals, Inc.

Market Cap

$7.64M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HeartSciences Inc.

Market Cap

$8.14M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Quince Therapeutics, Inc.

Market Cap

$7.46M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Healthcare Triangle, Inc.

Market Cap

$8.33M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Aprea Therapeutics, Inc. (APRE)	$7.87M	N/A	N/A	N/A	N/A
Traws Pharma, Inc. (TRAW)vs ›	$7.92M	N/A	N/A	N/A	N/A
CNS Pharmaceuticals, Inc. (CNSP)vs ›	$7.75M	N/A	N/A	N/A	N/A
GT Biopharma, Inc. (GTBP)vs ›	$8.04M	N/A	1206.46%	1192.40%	1192.40%
DataMEDS AI, Inc. (MEDS)vs ›	$8.05M	N/A	N/A	N/A	N/A
ENDRA Life Sciences Inc. (NDRA)vs ›	$7.67M	N/A	N/A	N/A	N/A
Mangoceuticals, Inc. (MGRX)vs ›	$7.64M	N/A	N/A	N/A	N/A
HeartSciences Inc. (HSCS)vs ›	$8.14M	N/A	N/A	N/A	N/A
Quince Therapeutics, Inc. (QNCX)vs ›	$7.46M	N/A	N/A	N/A	N/A
Healthcare Triangle, Inc. (HCTI)vs ›	$8.33M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics